vs
布鲁克（BRKR）与EyePoint, Inc.（EYPT）财务数据对比。点击上方公司名可切换其他公司
布鲁克的季度营收约是EyePoint, Inc.的1578.7倍（$977.2M vs $619.0K）。布鲁克净利率更高（2.7% vs -10922.3%，领先10925.0%）。布鲁克同比增速更快（-0.2% vs -94.7%）。布鲁克自由现金流更多（$207.2M vs $-66.0M）。过去两年布鲁克的营收复合增速更高（16.4% vs -77.0%）
布鲁克公司是美国科学仪器制造商，总部位于马萨诸塞州比勒里卡，为公开上市企业。公司产品服务于分子与材料研究、工业及应用分析领域，旗下设有布鲁克科学仪器、布鲁克能源与超导技术（BEST）两大业务板块。
EyePoint制药公司总部位于马萨诸塞州沃特敦，是一家专注于将微机电系统（MEMS）与纳米技术应用于给药领域的专业医药企业，依托前沿交叉技术开发创新给药方案，聚焦眼科等领域的药物递送技术创新与产品开发。
BRKR vs EYPT — 直观对比
营收规模更大
BRKR
是对方的1578.7倍
$619.0K
营收增速更快
BRKR
高出94.4%
-94.7%
净利率更高
BRKR
高出10925.0%
-10922.3%
自由现金流更多
BRKR
多$273.2M
$-66.0M
两年增速更快
BRKR
近两年复合增速
-77.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $977.2M | $619.0K |
| 净利润 | $26.0M | $-67.6M |
| 毛利率 | 46.0% | — |
| 营业利润率 | 7.8% | -11364.3% |
| 净利率 | 2.7% | -10922.3% |
| 营收同比 | -0.2% | -94.7% |
| 净利润同比 | 89.8% | -63.3% |
| 每股收益（稀释后） | $0.10 | $-0.82 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BRKREYPT
| Q4 25 | $977.2M | $619.0K | ||
| Q3 25 | $860.5M | $966.0K | ||
| Q2 25 | $797.4M | $5.3M | ||
| Q1 25 | $801.4M | $24.5M | ||
| Q4 24 | $979.6M | $11.6M | ||
| Q3 24 | $864.4M | $10.5M | ||
| Q2 24 | $800.7M | $9.5M | ||
| Q1 24 | $721.7M | $11.7M |
净利润BRKREYPT
| Q4 25 | $26.0M | $-67.6M | ||
| Q3 25 | $-59.6M | $-59.7M | ||
| Q2 25 | $7.6M | $-59.4M | ||
| Q1 25 | $17.4M | $-45.2M | ||
| Q4 24 | $13.7M | $-41.4M | ||
| Q3 24 | $40.9M | $-29.4M | ||
| Q2 24 | $7.6M | $-30.8M | ||
| Q1 24 | $50.9M | $-29.3M |
毛利率BRKREYPT
| Q4 25 | 46.0% | — | ||
| Q3 25 | 44.1% | — | ||
| Q2 25 | 44.9% | — | ||
| Q1 25 | 48.8% | — | ||
| Q4 24 | 50.4% | — | ||
| Q3 24 | 48.4% | 93.0% | ||
| Q2 24 | 48.0% | 85.2% | ||
| Q1 24 | 48.9% | 93.5% |
营业利润率BRKREYPT
| Q4 25 | 7.8% | -11364.3% | ||
| Q3 25 | -6.0% | -6420.8% | ||
| Q2 25 | 1.5% | -1166.8% | ||
| Q1 25 | 4.0% | -199.7% | ||
| Q4 24 | 7.4% | -390.4% | ||
| Q3 24 | 7.9% | -311.2% | ||
| Q2 24 | 6.0% | -364.5% | ||
| Q1 24 | 9.0% | -285.2% |
净利率BRKREYPT
| Q4 25 | 2.7% | -10922.3% | ||
| Q3 25 | -6.9% | -6183.4% | ||
| Q2 25 | 1.0% | -1114.3% | ||
| Q1 25 | 2.2% | -184.8% | ||
| Q4 24 | 1.4% | -357.3% | ||
| Q3 24 | 4.7% | -279.0% | ||
| Q2 24 | 0.9% | -325.3% | ||
| Q1 24 | 7.1% | -250.6% |
每股收益（稀释后）BRKREYPT
| Q4 25 | $0.10 | $-0.82 | ||
| Q3 25 | $-0.41 | $-0.85 | ||
| Q2 25 | $0.05 | $-0.85 | ||
| Q1 25 | $0.11 | $-0.65 | ||
| Q4 24 | $0.09 | $-0.65 | ||
| Q3 24 | $0.27 | $-0.54 | ||
| Q2 24 | $0.05 | $-0.58 | ||
| Q1 24 | $0.35 | $-0.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $298.8M | $306.1M |
| 总债务越低越好 | $1.9B | — |
| 股东权益账面价值 | $2.5B | $306.1M |
| 总资产 | $6.2B | $364.0M |
| 负债/权益比越低杠杆越低 | 0.76× | — |
8季度趋势，按日历期对齐
现金及短期投资BRKREYPT
| Q4 25 | $298.8M | $306.1M | ||
| Q3 25 | $293.1M | $204.0M | ||
| Q2 25 | $92.0M | $255.7M | ||
| Q1 25 | $184.2M | $318.2M | ||
| Q4 24 | $183.4M | $370.9M | ||
| Q3 24 | $148.1M | $253.8M | ||
| Q2 24 | $169.7M | $280.2M | ||
| Q1 24 | $340.1M | $299.3M |
总债务BRKREYPT
| Q4 25 | $1.9B | — | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | $2.4B | — | ||
| Q1 25 | $2.1B | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.3B | — | ||
| Q2 24 | $2.2B | — | ||
| Q1 24 | $1.4B | — |
股东权益BRKREYPT
| Q4 25 | $2.5B | $306.1M | ||
| Q3 25 | $2.4B | $200.2M | ||
| Q2 25 | $1.8B | $246.0M | ||
| Q1 25 | $1.8B | $298.4M | ||
| Q4 24 | $1.8B | $336.5M | ||
| Q3 24 | $1.8B | $218.7M | ||
| Q2 24 | $1.8B | $228.3M | ||
| Q1 24 | $1.4B | $249.9M |
总资产BRKREYPT
| Q4 25 | $6.2B | $364.0M | ||
| Q3 25 | $6.4B | $251.7M | ||
| Q2 25 | $6.3B | $301.1M | ||
| Q1 25 | $5.9B | $362.6M | ||
| Q4 24 | $5.8B | $418.5M | ||
| Q3 24 | $6.1B | $300.9M | ||
| Q2 24 | $5.9B | $324.2M | ||
| Q1 24 | $4.5B | $329.2M |
负债/权益比BRKREYPT
| Q4 25 | 0.76× | — | ||
| Q3 25 | 0.83× | — | ||
| Q2 25 | 1.34× | — | ||
| Q1 25 | 1.15× | — | ||
| Q4 24 | 1.18× | — | ||
| Q3 24 | 1.27× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.97× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $229.8M | $-65.0M |
| 自由现金流经营现金流 - 资本支出 | $207.2M | $-66.0M |
| 自由现金流率自由现金流/营收 | 21.2% | -10667.7% |
| 资本支出强度资本支出/营收 | 2.3% | 159.3% |
| 现金转化率经营现金流/净利润 | 8.84× | — |
| 过去12个月自由现金流最近4个季度 | $43.3M | $-243.4M |
8季度趋势，按日历期对齐
经营现金流BRKREYPT
| Q4 25 | $229.8M | $-65.0M | ||
| Q3 25 | $-33.2M | $-59.4M | ||
| Q2 25 | $-127.5M | $-62.6M | ||
| Q1 25 | $65.0M | $-53.1M | ||
| Q4 24 | $190.0M | $-35.8M | ||
| Q3 24 | $38.4M | $-39.0M | ||
| Q2 24 | $1.1M | $-20.2M | ||
| Q1 24 | $21.8M | $-31.2M |
自由现金流BRKREYPT
| Q4 25 | $207.2M | $-66.0M | ||
| Q3 25 | $-54.1M | $-60.2M | ||
| Q2 25 | $-148.8M | $-63.8M | ||
| Q1 25 | $39.0M | $-53.4M | ||
| Q4 24 | $153.3M | $-36.2M | ||
| Q3 24 | $5.8M | $-40.6M | ||
| Q2 24 | $-23.5M | $-21.1M | ||
| Q1 24 | $400.0K | $-32.4M |
自由现金流率BRKREYPT
| Q4 25 | 21.2% | -10667.7% | ||
| Q3 25 | -6.3% | -6226.9% | ||
| Q2 25 | -18.7% | -1196.5% | ||
| Q1 25 | 4.9% | -218.4% | ||
| Q4 24 | 15.6% | -312.7% | ||
| Q3 24 | 0.7% | -385.8% | ||
| Q2 24 | -2.9% | -222.4% | ||
| Q1 24 | 0.1% | -277.0% |
资本支出强度BRKREYPT
| Q4 25 | 2.3% | 159.3% | ||
| Q3 25 | 2.4% | 82.6% | ||
| Q2 25 | 2.7% | 22.9% | ||
| Q1 25 | 3.2% | 1.1% | ||
| Q4 24 | 3.7% | 3.3% | ||
| Q3 24 | 3.8% | 15.0% | ||
| Q2 24 | 3.1% | 9.5% | ||
| Q1 24 | 3.0% | 10.2% |
现金转化率BRKREYPT
| Q4 25 | 8.84× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -16.78× | — | ||
| Q1 25 | 3.74× | — | ||
| Q4 24 | 13.87× | — | ||
| Q3 24 | 0.94× | — | ||
| Q2 24 | 0.14× | — | ||
| Q1 24 | 0.43× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BRKR
| Bsi Nano | $309.1M | 32% |
| Bsi Biospin | $267.0M | 27% |
| Other | $179.9M | 18% |
| Transferred Over Time | $142.5M | 15% |
| Energy And Supercon Technologies | $69.5M | 7% |
EYPT
暂无分部数据
